Benzinga | Nov 5, 2020 07:08AM EST

Amicus Therapeutics Q3 EPS $(0.25) Misses $(0.22) Estimate, Sales $67.40M Beat $65.10M Estimate

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 4.17 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $67.40 million which beat the analyst consensus estimate of $65.10 million by 3.53 percent. This is a 38.21 percent increase over sales of $48.77 million the same period last year.